Alendronate for treatment of renal transplant patients with osteoporosis.
Chong
Christopher
C
D019386:Alendronate / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008159:Lumbar Vertebrae / Q000187:drug effects; D010024:Osteoporosis / Q000209:etiology*
D050071:Bone Density Conservation Agents; D007166:Immunosuppressive Agents; D019386:Alendronate